|  Help  |  About  |  Contact Us

Search our database by keyword

Examples

  • Search this entire website. Enter identifiers, names or keywords for genes, diseases, strains, ontology terms, etc. (e.g. Pax6, Parkinson, ataxia)
  • Use OR to search for either of two terms (e.g. OR mus) or quotation marks to search for phrases (e.g. "dna binding").
  • Boolean search syntax is supported: e.g. Balb* for partial matches or mus AND NOT embryo to exclude a term

Search results 1 to 100 out of 271 for Tafazzin

<< First    < Previous  |  Next >    Last >>
0.058s
Type Details Score
Protein Domain
Type: Family
Description: This entry includes tafazzin and its homologues, such as Taz1 from yeasts and N-acylphosphatidylethanolamine synthase from plants. Tafazzin is an enzyme involved in the cardiolipin remodelling pathway [, ]. The phospholipid cardiolipin is an important component of the inner mitochondrial membrane that is involved in mitochondrial energy production and apoptosis []. In humans tafazzin is expressed at high levels in cardiac and skeletal muscle. As many as 10 isoforms can be present in different amounts in different tissues. Isoforms with hydrophobic N-termini are thought to be membrane anchored, while shorter forms, lacking the hydrophobic stretch, may be cytoplasmic (these latter are found in leukocytes and fibroblasts, but not in heart and skeletal muscle). A central hydrophilic domain may serve as an exposed loop that interacts with other proteins. Defects in the taz gene are the cause of Barth syndrome, a severe inherited disorder, often fatal in childhood. The disease is characterised by cardiac and skeletal myopathy, short stature and neutropenia [].In flies tafazzin is a CoA-independent, acyl-specific phospholipid transacylase with substrate preference for cardiolipin and phosphatidylcholine [].Budding yeast Taz1 is a lyso-phosphatidylcholine acyltransferase that is required for normal phospholipid content of mitochondrial membranes, whose acyl specificity in the reaction relies on lipid chemical composition [, ]. Arabidopsis N-acylphosphatidylethanolamine synthase (NAPE synthase, At1g78690) is an acyltransferase that catalyses the N-acylation of phosphatidylethanolamine to form N-acylphosphatidylethanolamine (N-acyl-PE) [].
Gene
Type: gene
Organism: chicken
Gene
Type: gene
Organism: human
Gene
Type: gene
Organism: frog, western clawed
Gene
Type: gene
Organism: dog, domestic
Protein
Organism: Mus musculus/domesticus
Length: 262  
Fragment?: false
Gene
Type: gene
Organism: rat
Gene
Type: gene
Organism: chimpanzee
Gene
Type: gene
Organism: cattle
Gene
Type: gene
Organism: zebrafish
Gene
Type: gene
Organism: macaque, rhesus
Protein Coding Gene
Type: protein_coding_gene
Organism: mouse, laboratory
Protein
Organism: Mus musculus/domesticus
Length:  
Fragment?: false
Protein
Organism: Mus musculus/domesticus
Length: 21  
Fragment?: true
Publication
First Author: Schlame M
Year: 2017
Journal: J Biol Chem
Title: The Basis for Acyl Specificity in the Tafazzin Reaction.
Volume: 292
Issue: 13
Pages: 5499-5506
Publication
First Author: Houtkooper RH
Year: 2009
Journal: Biochim Biophys Acta
Title: The enigmatic role of tafazzin in cardiolipin metabolism.
Volume: 1788
Issue: 10
Pages: 2003-14
Publication
First Author: Bione S
Year: 1996
Journal: Nat Genet
Title: A novel X-linked gene, G4.5. is responsible for Barth syndrome.
Volume: 12
Issue: 4
Pages: 385-9
Publication
First Author: Testet E
Year: 2005
Journal: Biochem J
Title: Ypr140wp, 'the yeast tafazzin', displays a mitochondrial lysophosphatidylcholine (lyso-PC) acyltransferase activity related to triacylglycerol and mitochondrial lipid synthesis.
Volume: 387
Issue: Pt 3
Pages: 617-26
Publication
First Author: Bulat E
Year: 2011
Journal: J Biol Chem
Title: Putative N-acylphosphatidylethanolamine synthase from Arabidopsis thaliana is a lysoglycerophospholipid acyltransferase.
Volume: 286
Issue: 39
Pages: 33819-31
Publication
First Author: Malhotra A
Year: 2009
Journal: Proc Natl Acad Sci U S A
Title: Role of calcium-independent phospholipase A2 in the pathogenesis of Barth syndrome.
Volume: 106
Issue: 7
Pages: 2337-41
Publication
First Author: Xu Y
Year: 2006
Journal: J Biol Chem
Title: The enzymatic function of tafazzin.
Volume: 281
Issue: 51
Pages: 39217-24
Protein
Organism: Mus musculus/domesticus
Length: 248  
Fragment?: false
Protein
Organism: Mus musculus/domesticus
Length: 175  
Fragment?: false
Protein
Organism: Mus musculus/domesticus
Length: 238  
Fragment?: false
Protein
Organism: Mus musculus/domesticus
Length: 177  
Fragment?: false
Protein
Organism: Mus musculus/domesticus
Length: 189  
Fragment?: false
Protein
Organism: Mus musculus/domesticus
Length: 64  
Fragment?: true
Protein
Organism: Mus musculus/domesticus
Length: 178  
Fragment?: true
Protein
Organism: Mus musculus/domesticus
Length: 134  
Fragment?: true
Protein
Organism: Mus musculus/domesticus
Length: 263  
Fragment?: false
Protein
Organism: Mus musculus/domesticus
Length: 150  
Fragment?: true
Protein
Organism: Mus musculus/domesticus
Length: 148  
Fragment?: true
Publication
First Author: Acehan D
Year: 2009
Journal: Mitochondrion
Title: Distinct effects of tafazzin deletion in differentiated and undifferentiated mitochondria.
Volume: 9
Issue: 2
Pages: 86-95
Publication
First Author: Soustek MS
Year: 2011
Journal: Hum Gene Ther
Title: Characterization of a transgenic short hairpin RNA-induced murine model of Tafazzin deficiency.
Volume: 22
Issue: 7
Pages: 865-71
Publication  
First Author: Phoon CK
Year: 2012
Journal: J Am Heart Assoc
Title: Tafazzin knockdown in mice leads to a developmental cardiomyopathy with early diastolic dysfunction preceding myocardial noncompaction.
Volume: 1
Issue: 2
Publication
First Author: Cole LK
Year: 2018
Journal: Biochim Biophys Acta Mol Basis Dis
Title: Aberrant cardiolipin metabolism is associated with cognitive deficiency and hippocampal alteration in tafazzin knockdown mice.
Volume: 1864
Issue: 10
Pages: 3353-3367
Publication
First Author: Cadalbert LC
Year: 2015
Journal: PLoS One
Title: Mouse Tafazzin Is Required for Male Germ Cell Meiosis and Spermatogenesis.
Volume: 10
Issue: 6
Pages: e0131066
Publication  
First Author: Kim J
Year: 2018
Journal: Mitochondrion
Title: Cardiac mitochondrial structure and function in tafazzin-knockdown mice.
Volume: 43
Pages: 53-62
Publication
First Author: Hsu P
Year: 2015
Journal: Autophagy
Title: Cardiolipin remodeling by TAZ/tafazzin is selectively required for the initiation of mitophagy.
Volume: 11
Issue: 4
Pages: 643-52
Publication
First Author: Acehan D
Year: 2011
Journal: J Biol Chem
Title: Cardiac and skeletal muscle defects in a mouse model of human Barth syndrome.
Volume: 286
Issue: 2
Pages: 899-908
Publication
First Author: Maguire ARR
Year: 2021
Journal: Immunohorizons
Title: Tafazzin Modulates Allergen-Induced Mast Cell Inflammatory Mediator Secretion.
Volume: 5
Issue: 4
Pages: 182-192
Publication
First Author: Le CH
Year: 2020
Journal: J Biol Chem
Title: Tafazzin deficiency impairs CoA-dependent oxidative metabolism in cardiac mitochondria.
Volume: 295
Issue: 35
Pages: 12485-12497
UniProt Feature
Begin: 1
Description: Tafazzin
Type: chain
End: 262
Publication  
First Author: Powers C
Year: 2013
Journal: Front Physiol
Title: Diminished Exercise Capacity and Mitochondrial bc1 Complex Deficiency in Tafazzin-Knockdown Mice.
Volume: 4
Pages: 74
Publication
First Author: Kimura T
Year: 2018
Journal: Biochemistry
Title: Substantial Decrease in Plasmalogen in the Heart Associated with Tafazzin Deficiency.
Volume: 57
Issue: 14
Pages: 2162-2175
Gene
Type: gene
Organism: cattle
Publication  
First Author: Cole LK
Year: 2021
Journal: Endocrinology
Title: Tafazzin Deficiency Reduces Basal Insulin Secretion and Mitochondrial Function in Pancreatic Islets From Male Mice.
Volume: 162
Issue: 7
Publication
First Author: Zegallai HM
Year: 2022
Journal: FASEB J
Title: Tafazzin deficiency in mouse mesenchymal stem cells promote reprogramming of activated B lymphocytes toward immunosuppressive phenotypes.
Volume: 36
Issue: 8
Pages: e22443
Publication
First Author: Wang S
Year: 2023
Journal: Hum Mol Genet
Title: Genetic modifiers modulate phenotypic expression of tafazzin deficiency in a mouse model of Barth syndrome.
Volume: 32
Issue: 12
Pages: 2055-2067
Publication
First Author: Zegallai HM
Year: 2021
Journal: FASEB J
Title: Tafazzin deficiency impairs mitochondrial metabolism and function of lipopolysaccharide activated B lymphocytes in mice.
Volume: 35
Issue: 12
Pages: e22023
Publication
First Author: Sohn J
Year: 2022
Journal: Blood Adv
Title: A new murine model of Barth syndrome neutropenia links TAFAZZIN deficiency to increased ER stress-induced apoptosis.
Volume: 6
Issue: 8
Pages: 2557-2577
Publication
First Author: Szczepanek K
Year: 2016
Journal: Biochim Biophys Acta
Title: Acquired deficiency of tafazzin in the adult heart: Impact on mitochondrial function and response to cardiac injury.
Volume: 1861
Issue: 4
Pages: 294-300
Publication
First Author: Ren M
Year: 2019
Journal: Am J Physiol Heart Circ Physiol
Title: A critical appraisal of the tafazzin knockdown mouse model of Barth syndrome: what have we learned about pathogenesis and potential treatments?
Volume: 317
Issue: 6
Pages: H1183-H1193
Publication
First Author: Zhu S
Year: 2022
Journal: Circulation
Title: Mitochondrial Stress Induces an HRI-eIF2α Pathway Protective for Cardiomyopathy.
Volume: 146
Issue: 13
Pages: 1028-1031
Publication
First Author: Seneviratne AK
Year: 2019
Journal: Cell Stem Cell
Title: The Mitochondrial Transacylase, Tafazzin, Regulates for AML Stemness by Modulating Intracellular Levels of Phospholipids.
Volume: 24
Issue: 4
Pages: 621-636.e16
Publication
First Author: Chowdhury A
Year: 2018
Journal: Cell Rep
Title: Defective Mitochondrial Cardiolipin Remodeling Dampens HIF-1α Expression in Hypoxia.
Volume: 25
Issue: 3
Pages: 561-570.e6
Publication      
First Author: Goncalves RLS
Year: 2020
Journal: FEBS Lett
Title: Cardiolipin deficiency in Barth syndrome is not associated with increased superoxide/H2 O2 production in heart and skeletal muscle mitochondria.
Publication
First Author: Ikon N
Year: 2018
Journal: J Biomed Res
Title: Evaluation of cardiolipin nanodisks as lipid replacement therapy for Barth syndrome
Volume: 32
Issue: 2
Pages: 107-112
Publication
First Author: Wang S
Year: 2020
Journal: Circ Res
Title: AAV Gene Therapy Prevents and Reverses Heart Failure in a Murine Knockout Model of Barth Syndrome.
Volume: 126
Issue: 8
Pages: 1024-1039
Publication
First Author: Braun JL
Year: 2019
Journal: Physiol Rep
Title: SERCA2a tyrosine nitration coincides with impairments in maximal SERCA activity in left ventricles from tafazzin-deficient mice.
Volume: 7
Issue: 16
Pages: e14215
Publication  
First Author: Johnson JM
Year: 2018
Journal: J Mol Cell Cardiol
Title: Targeted overexpression of catalase to mitochondria does not prevent cardioskeletal myopathy in Barth syndrome.
Volume: 121
Pages: 94-102
Publication  
First Author: Suzuki-Hatano S
Year: 2019
Journal: Mol Ther Methods Clin Dev
Title: AAV9-TAZ Gene Replacement Ameliorates Cardiac TMT Proteomic Profiles in a Mouse Model of Barth Syndrome.
Volume: 13
Pages: 167-179
Publication  
First Author: Kimura T
Year: 2019
Journal: Life Sci Alliance
Title: Plasmalogen loss caused by remodeling deficiency in mitochondria.
Volume: 2
Issue: 4
Publication
First Author: Kiebish MA
Year: 2013
Journal: J Lipid Res
Title: Dysfunctional cardiac mitochondrial bioenergetic, lipidomic, and signaling in a murine model of Barth syndrome.
Volume: 54
Issue: 5
Pages: 1312-25
Publication
First Author: Soustek MS
Year: 2015
Journal: J Inherit Metab Dis
Title: Endurance training ameliorates complex 3 deficiency in a mouse model of Barth syndrome.
Volume: 38
Issue: 5
Pages: 915-22
Publication
First Author: Li Y
Year: 2019
Journal: J Biol Chem
Title: Cardiolipin-induced activation of pyruvate dehydrogenase links mitochondrial lipid biosynthesis to TCA cycle function.
Volume: 294
Issue: 30
Pages: 11568-11578
Publication
First Author: Zhu S
Year: 2021
Journal: Circ Heart Fail
Title: Cardiolipin Remodeling Defects Impair Mitochondrial Architecture and Function in a Murine Model of Barth Syndrome Cardiomyopathy.
Volume: 14
Issue: 6
Pages: e008289
Publication
First Author: Suzuki-Hatano S
Year: 2019
Journal: Hum Gene Ther
Title: AAV-Mediated TAZ Gene Replacement Restores Mitochondrial and Cardioskeletal Function in Barth Syndrome.
Volume: 30
Issue: 2
Pages: 139-154
Publication
First Author: Corrado M
Year: 2020
Journal: Cell Metab
Title: Dynamic Cardiolipin Synthesis Is Required for CD8+ T Cell Immunity.
Volume: 32
Issue: 6
Pages: 981-995.e7
Publication  
First Author: Cole LK
Year: 2020
Journal: J Mol Cell Cardiol
Title: Cardiolipin deficiency elevates susceptibility to a lipotoxic hypertrophic cardiomyopathy.
Volume: 144
Pages: 24-34
Publication
First Author: Bertero E
Year: 2021
Journal: Circulation
Title: Loss of Mitochondrial Ca2+ Uniporter Limits Inotropic Reserve and Provides Trigger and Substrate for Arrhythmias in Barth Syndrome Cardiomyopathy.
Volume: 144
Issue: 21
Pages: 1694-1713
Publication
First Author: Lu B
Year: 2004
Journal: Biochem Cell Biol
Title: Complex expression pattern of the Barth syndrome gene product tafazzin in human cell lines and murine tissues.
Volume: 82
Issue: 5
Pages: 569-76
Publication
First Author: Ostojic O
Year: 2013
Journal: J Appl Physiol (1985)
Title: The effects of chronic muscle use and disuse on cardiolipin metabolism.
Volume: 114
Issue: 4
Pages: 444-52
Protein Coding Gene
Type: protein_coding_gene
Organism: Mus caroli
Protein Coding Gene
Type: protein_coding_gene
Organism: mouse, laboratory
Protein Coding Gene
Type: protein_coding_gene
Organism: mouse, laboratory
Protein Coding Gene
Type: protein_coding_gene
Organism: mouse, laboratory
Protein Coding Gene
Type: protein_coding_gene
Organism: mouse, laboratory
Protein Coding Gene
Type: protein_coding_gene
Organism: mouse, laboratory
Protein Coding Gene
Type: protein_coding_gene
Organism: mouse, laboratory
Protein Coding Gene
Type: protein_coding_gene
Organism: mouse, laboratory
Protein Coding Gene
Type: protein_coding_gene
Organism: mouse, laboratory
Protein Coding Gene
Type: protein_coding_gene
Organism: mouse, laboratory
Protein Coding Gene
Type: protein_coding_gene
Organism: mouse, laboratory
Protein Coding Gene
Type: protein_coding_gene
Organism: mouse, laboratory
Protein Coding Gene
Type: protein_coding_gene
Organism: mouse, laboratory
Protein Coding Gene
Type: protein_coding_gene
Organism: mouse, laboratory
Protein Coding Gene
Type: protein_coding_gene
Organism: mouse, laboratory
Protein Coding Gene
Type: protein_coding_gene
Organism: mouse, laboratory
Protein Coding Gene
Type: protein_coding_gene
Organism: mouse, laboratory
Protein Coding Gene
Type: protein_coding_gene
Organism: Mus pahari
Protein Coding Gene
Type: protein_coding_gene
Organism: Mus spretus
GXD Expression      
Probe: MGI:7620338
Assay Type: RT-PCR
Annotation Date: 2024-04-12
Strength: Present
Sex: Not Specified
Emaps: EMAPS:1610528
Stage: TS28
Assay Id: MGI:7620353
Age: postnatal day 10
Specimen Label: Ctrl
Detected: true
Specimen Num: 1
GXD Expression      
Probe: MGI:7620338
Assay Type: RT-PCR
Annotation Date: 2024-04-12
Strength: Present
Sex: Not Specified
Emaps: EMAPS:1610528
Stage: TS28
Assay Id: MGI:7620353
Age: postnatal day 10
Specimen Label: cKO
Detected: true
Specimen Num: 2
GXD Expression      
Probe: MGI:7620338
Assay Type: RT-PCR
Annotation Date: 2024-04-12
Strength: Absent
Sex: Not Specified
Emaps: EMAPS:1610528
Stage: TS28
Assay Id: MGI:7620353
Age: postnatal day 10
Specimen Label: TKO
Detected: false
Specimen Num: 3
GXD Expression      
Probe: MGI:7620338
Assay Type: RT-PCR
Annotation Date: 2024-04-12
Strength: Absent
Sex: Not Specified
Emaps: EMAPS:1610528
Stage: TS28
Assay Id: MGI:7620353
Age: postnatal day 10
Specimen Label: dcKO
Detected: false
Specimen Num: 4
GXD Expression      
Probe: MGI:5309817
Assay Type: RNA in situ
Annotation Date: 2012-06-12
Strength: Absent
Sex: Not Specified
Emaps: EMAPS:3516422
Stage: TS22
Assay Id: MGI:5423143
Age: embryonic day 14.5
Specimen Label: EB28; Specimen B152
Detected: false
Specimen Num: 1
GXD Expression      
Probe: MGI:5309817
Assay Type: RNA in situ
Annotation Date: 2012-06-12
Strength: Absent
Sex: Not Specified
Emaps: EMAPS:1716122
Stage: TS22
Assay Id: MGI:5423143
Age: embryonic day 14.5
Specimen Label: EB28; Specimen B152
Detected: false
Specimen Num: 1
GXD Expression      
Probe: MGI:5309817
Assay Type: RNA in situ
Annotation Date: 2012-06-12
Strength: Absent
Sex: Not Specified
Emaps: EMAPS:1691622
Stage: TS22
Assay Id: MGI:5423143
Age: embryonic day 14.5
Specimen Label: EB28; Specimen B152
Detected: false
Specimen Num: 1
GXD Expression      
Probe: MGI:5309817
Assay Type: RNA in situ
Annotation Date: 2012-06-12
Strength: Absent
Sex: Not Specified
Emaps: EMAPS:1760622
Stage: TS22
Assay Id: MGI:5423143
Age: embryonic day 14.5
Specimen Label: EB28; Specimen B152
Detected: false
Specimen Num: 1